Table 3.
Cardiovascular (CV) and bleeding events during follow-up in the whole cohort (n=10 069)
| Type of event | Patients with event (%)* | Total number of events (fatal) |
|---|---|---|
| All CV | 978 (9.8%) | 1173 (281) |
| Coronary | 559 (5.7%) | 653 (65) |
| MI | 238 (2.5%) | 252 (45) |
| Heart failure | 104 (1.1%) | 117 (30) |
| Arrhythmia | 88 (0.9%) | 93 (13) |
| Sudden death | 8 (0.1%) | 8 (8) |
| Chest pain | 14 (0.1%) | 18 (0) |
| Cerebrovascular | 50 (0.5%) | 56 (8) |
| Other | 71 (0.7%) | 75 (7) |
| Not classified | 151 (1.5%) | 153 (150) |
| Bleeding | 366 (3.6%) | 492 (14) |
| Clinically relevant bleeds | 168 (1.7%) | 223 (14) |
| Bleeds requiring hospitalisation | 158 (1.5%) | 212 (8) |
| Bleeds with haemodynamic compromise | 33 (0.3%) | 37 (3) |
| Intracranial bleeds | 15 (0.2%) | 15 (6) |
| Other bleeds | 226 (2.2%) | 269 (0) |
| Deaths not due to CV or bleeding | ||
| Deaths of unknown cause | 84 (0.9%) | 84 (84) |
*Percentages are Kaplan-Meier estimates at 23 months.
MI, myocardial infarction.